The Promises and Pitfalls of Gene Therapy for Rare Diseases: Strategies for Maximizing Reg Success

Emily Woodward, Director, Customer Engagement Regulatory Services at Certara dives into strategies for maximizing regulatory success for your gene therapy program.

Certara accelerates medicines to patients using proprietary biosimulation software and technology to transform traditional drug discovery and development. Its clients include 1,600 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 60 countries.

Please visit us at https://www.certara.com/